BCRX BioCryst Pharmaceuticals, Inc.

$8.12▼ -2.05% Healthcare Other
After hours $8.12▲ +0.00% Sep 11, 7:53 PM ET
Volume 3.58M Avg Volume (10D) 4.17M
Key Metrics & Fundamentals
Market Cap
$2.07B
P/E Ratio
–
Div Yield
–%
52W Range
6.00 - 11.22
% vs 50 MA
-15.86%
% vs 200 MA
-5.62%
RSI-14
29.8
MACD Histogram
-0.2000
Beta (1Y vs SPY)
0.63
Free Cash Flow
$104.13M
Gross Rev
$218.25M
Gross Profit
$214.41M
EBITDA
$101.67M
COGS
$3.84M
Operating Exp
$115.95M
Operating Income
$98.47M
EBIT
$98.47M
Pretax Income
$79.47M
Net Income
$78.40M
EPS (Diluted)
0.30
Price & Volume History
Loading chart…
Recent News
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Sep 10, 2026 7:49 PM
Sector Update: Healthcare Stocks Softer in Afternoon Trading
MT Newswires · Sep 10, 2026 5:45 PM
BCRX Stock Heads For Fifth Straight Day In The Red – RBC Capital Says BioCryst Faces A ‘Challenging Near-Term Outlook’
Stocktwits · Sep 10, 2026 3:52 PM
BioCryst Pharmaceuticals Faces Competitive Pressure in Hereditary Angioedema Treatment, RBC Says
MT Newswires · Sep 10, 2026 3:42 PM
RBC Downgrades BioCryst Pharmaceuticals to Sector Perform From Outperform, Cuts Price Target to $11 From $13
MT Newswires · Sep 10, 2026 10:30 AM
BCRX Stock Posts Worst Day In Over 6 Months After PHVS Trial Win In Rare Swelling Disease
Stocktwits · Sep 8, 2026 11:24 PM
CareMed Has Been Selected as a National Pharmacy Partner by BioCryst and Adds Orladeyo® (berotralstat) to Growing Rare Disease Portfolio
GlobeNewswire · Sep 8, 2026 8:45 PM
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
MarketBeat · Sep 6, 2026 12:50 PM
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
Insider Monkey · Sep 2, 2026 1:15 PM
BioCryst to Present at Upcoming Investor Conference
GlobeNewswire · Sep 1, 2026 11:00 AM
Financial Overview - Income Statement Quarterly

See BCRX's money flow as a full page

Social Sentiment
Avg +0.66 · 5 posts
NewsDiscussionI ran Joel Greenblatt’s Magic Formula for 1 year. Finished +35.48%. Here’s what happened.
r/investing · Apr 28, 2026
The post highlights BCRX as a component of the portfolio, acknowledging its biotech focus.
positive +0.20
NewsTradeDiscussionFDA approves BioCryst's oral pellet version of rare disease drug for children.
r/wallstreetbets · Dec 12, 2025
The approval of a key drug is a positive event for the company.
very_positive +0.90
TradeEarningsAnalysis of Earnings Reports for Week 08/04
r/wallstreetbets · Aug 8, 2025
Part of a list of winning options, suggesting positive performance.
positive +0.60
EarningsPriceTargetDDBCRX
r/wallstreetbets · Aug 4, 2025
The post expresses strong optimism regarding BCRX's future performance and growth potential.
positive +0.80
DDNewsDiscussionBCRX is about to rocket.
r/wallstreetbets · Jan 28, 2025
The post expresses a strong bullish sentiment ('about to rocket') regarding BCRX.
positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙